GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Registered Plan Private Investments Inc (OTCPK:LXGTF) » Definitions » 5-Year EBITDA Growth Rate

Registered Plan Private Investments (Registered Plan Private Investments) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2019)


View and export this data going back to 2017. Start your Free Trial

What is Registered Plan Private Investments 5-Year EBITDA Growth Rate?

Registered Plan Private Investments's EBITDA per Share for the three months ended in Dec. 2019 was $-0.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Registered Plan Private Investments's 5-Year EBITDA Growth Rate

For the Asset Management subindustry, Registered Plan Private Investments's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Registered Plan Private Investments's 5-Year EBITDA Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Registered Plan Private Investments's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Registered Plan Private Investments's 5-Year EBITDA Growth Rate falls into.



Registered Plan Private Investments 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Registered Plan Private Investments  (OTCPK:LXGTF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Registered Plan Private Investments 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Registered Plan Private Investments's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Registered Plan Private Investments (Registered Plan Private Investments) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 1900, Vancouver, BC, CAN, V6E 2E9
Registered Plan Private Investments Inc is a private investment platform company that allows investors to use their Registered Plans (including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans) at their direction to invest in private companies by purchasing tracking shares in RPPI, which in turn uses these proceeds to invest in the specific private company chosen by the investor.

Registered Plan Private Investments (Registered Plan Private Investments) Headlines

From GuruFocus

Lexington Biosciences Announces Termination of Private Placement

By Marketwired Marketwired 02-15-2019

Lexington Provides Q3 Corporate Review

By Marketwired Marketwired 10-24-2018

Lexington Biosciences Announces Results of Annual General Meeting

By Marketwired Marketwired 07-03-2018

Lexington Biosciences Provides Update on Financial Situation

By Marketwired Marketwired 04-02-2019

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

By Marketwired Marketwired 07-25-2018

Lexington Announces First Multicenter Clinical Study Site

By Marketwired Marketwired 08-21-2018

Lexington Releases Audited Consolidated Financial Statements

By Marketwired Marketwired 05-01-2018